Concepedia

Michael W. DeGregorio

MW

62

Publications

2.7K

Citations

25

H-Index

1982

Active since

Affiliations

University of California, Davis(Current)

University of California, San Francisco

Cancer Research Institute

Palmetto Hematology Oncology

The University of Texas Health Science Center at San Antonio

Michael W. DeGregorio is an author at University of California, Davis specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyRadiation OncologyOncologyCancer ResearchBreast CancerTumor BiologyCancer TherapyHealth

Publications per year

1982–2022

62

Publications

62

Fungal infections in patients with acute leukemia

Michael W. DeGregorio, William M. F. Lee, Charles Linker et al. · The American Journal of Medicine · 1982 · 359 citations

Acute Leukemia, Clinical Mycology, Hematology +1

Acquired Tamoxifen Resistance: Correlation With Reduced Breast Tumor Levels of Tamoxifen and Isomerization of Trans-4-Hydroxytamoxifen

C. Kent Osborne, Ester B. Coronado, D. Craig Allred et al. · JNCI Journal of the National Cancer Institute · 1991 · 235 citations

Breast Oncology, Tamoxifen Resistance, Medicine +13

Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

Michael W. DeGregorio, William M. F. Lee, Curt A. Ries · Cancer · 1982 · 159 citations · Full text

Translational Medicine, Antibiotics, Candida Infections +12

Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug.

Kent E. Wallner, Michael W. DeGregorio, Gloria C. Li · PubMed · 1986 · 143 citations

Medicinal Chemistry, Biochemistry, Ddp Resistance +15

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

C. Kent Osborne, V. Wiebe, William McGuire et al. · Journal of Clinical Oncology · 1992 · 142 citations

Rows per page

1–5 of 62